recast-jats-buildd8e1462159jitcJ Immunother CancerjitcJournal for ImmunoTherapy of CancerJ Immunother CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltdjitc-2020-0485-9corr10.1136/jitc-2020-0485-9corr32152219/jitc/8/1/e0485-9corr.atomCorrectionOpen accessSpecial collectionsOpen accessCorrection: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy 32020532020201220192012201993202081e0485-9corr© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.2020https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.special-featureunlocked

Hanoteau A, Newton JM, Krupar R, et al. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. J Immunother Cancer 2019;7:10. doi: 10.1186/s40425-018-0485-9.

Since the online publication of this article, the authors have noticed that the funding acknowledgement is incomplete. As indicated in the funding acknowledgement, the study was partially funded by grant CPRIT RR160027 from the Cancer Prevention & Research Institutes of Texas. BZ is a CPRIT Scholar in Cancer Research.